Bessemer Group’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-45
Closed -$1K 2683
2024
Q3
$1K Buy
+45
New +$1K ﹤0.01% 2545